Insider Transactions in Q3 2023 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,384
+3.4%
|
$37,368
$27.08 P/Share
|
|
Sep 29
2023
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,384
+2.97%
|
$37,368
$27.08 P/Share
|
|
Aug 10
2023
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
37,500
-4.53%
|
$1,125,000
$30.75 P/Share
|
|
Aug 09
2023
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
37,500
-4.34%
|
$1,125,000
$30.72 P/Share
|
|
Jul 13
2023
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
37,500
-4.16%
|
$1,125,000
$30.93 P/Share
|
|
Jul 12
2023
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
37,500
-3.99%
|
$1,162,500
$31.07 P/Share
|